statistiche ricercatore

Continente	#
NA - Nord America	746
EU - Europa	283
AS - Asia	246
SA - Sud America	79
Continente sconosciuto - Info sul continente non disponibili	57
AF - Africa	17
Totale	1.428

Nazione	#
US - Stati Uniti d'America	729
SG - Singapore	90
IT - Italia	75
BR - Brasile	62
RU - Federazione Russa	51
VN - Vietnam	41
CN - Cina	39
DE - Germania	36
SE - Svezia	32
HK - Hong Kong	26
GB - Regno Unito	24
FI - Finlandia	22
FR - Francia	17
CI - Costa d'Avorio	11
CA - Canada	10
BD - Bangladesh	8
IN - India	8
EC - Ecuador	6
ES - Italia	6
ID - Indonesia	5
PK - Pakistan	5
AT - Austria	4
IQ - Iraq	4
SA - Arabia Saudita	4
AR - Argentina	3
CO - Colombia	3
EG - Egitto	3
JP - Giappone	3
LT - Lituania	3
PL - Polonia	3
UA - Ucraina	3
AZ - Azerbaigian	2
CL - Cile	2
CR - Costa Rica	2
GT - Guatemala	2
NP - Nepal	2
TR - Turchia	2
UZ - Uzbekistan	2
AE - Emirati Arabi Uniti	1
AM - Armenia	1
AO - Angola	1
BE - Belgio	1
CH - Svizzera	1
CW - ???statistics.table.value.countryCode.CW???	1
CZ - Repubblica Ceca	1
DK - Danimarca	1
GY - Guiana	1
HN - Honduras	1
JO - Giordania	1
LV - Lettonia	1
MA - Marocco	1
MT - Malta	1
NL - Olanda	1
PA - Panama	1
PE - Perù	1
PS - Palestinian Territory	1
SN - Senegal	1
SV - El Salvador	1
TJ - Tagikistan	1
VE - Venezuela	1
Totale	1.372

Nome	#
Implementation of the Frailty Index in hospitalized older patients: Results from the REPOSI register	224
Polypharmacy in older people: Lessons from 10 years of experience with the REPOSI register	221
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids	205
Mortality rate and risk factors for gastrointestinal bleeding in elderly patients	184
Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry	163
ADIPOQ rs266729 G/C gene polymorphism and plasmatic adipocytokines connect metabolic syndrome to colorectal cancer	159
Hyperglycemia at admission, comorbidities, and in-hospital mortality in elderly patients hospitalized in internal medicine wards: data from the RePoSI Registry	137
Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3, randomised, controlled trial	135
Totale	1.428

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	62	0	0	0	0	5	9	2	5	9	3	9	20
2022/2023	129	13	21	14	12	10	13	7	17	15	1	4	2
2023/2024	38	1	5	6	0	9	12	0	0	0	2	0	3
2024/2025	242	7	3	20	10	5	18	45	25	9	14	30	56
2025/2026	463	82	18	42	48	47	26	53	9	54	38	15	31
2026/2027	130	6	20	48	44	12	0	0	0	0	0	0	0
Totale													1.428